IGF-independent effects of insulin-like growth factor binding protein-5 (Igfbp5) in vivo

FASEB Journal

Volumn 23, Issue 8, 2009, Pages 2616-2626

  Tripathi, Gyanendra ^a,b   Salih, Dervis A M ^a,c   Drozd, Anja C ^a   Cosgrove, Ruth A ^a   Cobb, Laura J ^a,d   Pell, Jennifer M ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Muscle; Transgenic

Indexed keywords

MUTANT PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 5; MESSENGER RNA; PRIMER DNA; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; FEMALE; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE MUTANT; MUSCLE DEVELOPMENT; MUTATION; NUCLEOTIDE SEQUENCE; PREGNANCY; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

MUS;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUTATION; PHENOTYPE; PREGNANCY; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SOMATOMEDINS; TISSUE DISTRIBUTION;

EID: 68849103759     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-114124     Document Type: Article

References (50)

1. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72 (Pubitemid 23306021)
2. Baserga, R., Peruzzi, F., and Reiss, K. (2003) The IGF-1 receptor in cancer biology. Int. J. Cancer 107, 873-877
3. Ludwig, T., Eggenschwiler, J., Fisher, P., D'Ercole, A. J., Davenport, M. L., and Efstratiadis, A. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol. 177, 517-535 (Pubitemid 26275902)
4. Clemmons, D. R., Busby, W. H., Arai, T., Nam, T. J., Clarke, J. B., Jones, J. I., and Ankrapp, D. K. (1995) Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog. Growth. Factor. Res. 6, 357-366
5. Zeslawski, W., Beisel, H. G., Kamionka, M., Kalus, W., Engh, R. A., Huber, R., Lang, K., and Holak, T. A. (2001) The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J. 20, 3638-3644 (Pubitemid 32691775)
6. Imai, Y., Moralez, A., Andag, U., Clarke, J. B., Busby, W. H., Jr., and Clemmons, D. R. (2000) Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J. Biol. Chem. 275, 18188-18194 (Pubitemid 30414770)
7. Baxter, R. C., Meka, S., and Firth, S. M. (2002) Molecular distribution of IGF binding protein-5 in human serum. J. Clin. Endocrinol. Metab. 87, 271-276 (Pubitemid 34084701)
8. Green, B. N., Jones, S. B., Streck, R. D., Wood, T. L., Rotwein, P., and Pintar, J. E. (1994) Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 134, 954-962 (Pubitemid 24057245)
9. James, P. L., Stewart, C. E., and Rotwein, P. (1996) Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell Biol. 133, 683-693
10. Ishibashi, J., Perry, R. L., Asakura, A., and Rudnicki, M. A. (2005) MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. J. Cell Biol. 171, 471-482 (Pubitemid 41586936)
11. Stolf, B. S., Carvalho, A. F., Martins, W. K., Runza, F. B., Brun, M., Hirata, R., Jr., Jordao Neves, E., Soares, F. A., Postigo-Dias, J., Kowalski, L. P., and Reis, L. F. (2003) Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett. 191, 193-202 (Pubitemid 36255605)
12. Tsibris, J. C., Segars, J., Coppola, D., Mane, S., Wilbanks, G. D., O'Brien, W. F., and Spellacy, W. N. (2002) Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil. Steril. 78, 114-121 (Pubitemid 34722680)
13. Miyake, H., Pollak, M., and Gleave, M. E. (2000) Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res. 60, 3058-3064 (Pubitemid 30395835)
14. Khan, J., Bittner, M. L., Saal, L. H., Teichmann, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M., and Meltzer, P. S. (1999) cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. U. S. A. 96, 13264-13269
15. Li, X., Cao, X., Li, X., Zhang, W., and Feng, Y. (2007) Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer Cancer Sci. 98, 1592-1596 (Pubitemid 47308456)
16. Salih, D. A., Tripathi, G., Holding, C., Szestak, T. A., Gonzalez, M. I., Carter, E. J., Cobb, L. J., Eisemann, J. E., and Pell, J. M. (2004) Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. U. S. A. 101, 4314-4319 (Pubitemid 38405926)
17. Schedlich, L. J., Young, T. F., Firth, S. M., and Baxter, R. C. (1998) Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273, 18347-18352
18. Xu, Q., Li, S., Zhao, Y., Maures, T. J., Yin, P., and Duan, C. (2004) Evidence that IGF binding protein-5 functions as a ligand-independent transcriptional regulator in vascular smooth muscle cells. Circ. Res. 94, E46-54
19. Amaar, Y. G., Thompson, G. R., Linkhart, T. A., Chen, S. T., Baylink, D. J., and Mohan, S. (2002) Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J. Biol. Chem. 277, 12053-12060
20. Zhao, Y., Yin, P., Bach, L. A., and Duan, C. (2006) Several acidic amino acids in the N-domain of insulin-like growth factor-binding protein-5 are important for its transactivation activity. J. Biol. Chem. 281, 14184-14191 (Pubitemid 43848346)
21. Andress, D. L. (1998) Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am. J. Physiol. 274, E744-750
22. Miyakoshi, N., Richman, C., Kasukawa, Y., Linkhart, T. A., Baylink, D. J., and Mohan, S. (2001) Evidence that IGF-binding protein-5 functions as a growth factor. J. Clin. Invest. 107, 73-81 (Pubitemid 32047416)
23. Tanno, B., Cesi, V., Vitali, R., Sesti, F., Giuffrida, M. L., Mancini, C., Calabretta, B., and Raschella, G. (2005) Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells. Cell Death Differ. 12, 213-223 (Pubitemid 40360945)
24. Cobb, L. J., Salih, D. A., Gonzalez, I., Tripathi, G., Carter, E. J., Lovett, F., Holding, C., and Pell, J. M. (2004) Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function. J. Cell Sci. 117, 1737-1746 (Pubitemid 38559306)
25. Perks, C. M., McCaig, C., Clarke, J. B., Clemmons, D. R., and Holly, J. M. (2002) Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells. Biochem. Biophys. Res. Commun. 294, 995-1000 (Pubitemid 34687148)
26. Gonzalez, I., Tripathi, G., Carter, E. J., Cobb, L. J., Salih, D. A., Lovett, F. A., Holding, C., and Pell, J. M. (2004) Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol. Cell. Biol. 24, 3607-3622 (Pubitemid 38496142)
27. Kawarabayashi, T., Shoji, M., Sato, M., Sasaki, A., Ho, L., Eckman, C. B., Prada, C. M., Younkin, S. G., Kobayashi, T., Tada, N., Matsubara, E., Iizuka, T., Harigaya, Y., Kasai, K., and Hirai, S. (1996) Accumulation of beta-amyloid fibrils in pancreas of transgenic mice. Neurobiol. Aging. 17, 215-222 (Pubitemid 26167633)
28. Florini, J. R., Ewton, D. Z., and Coolican, S. A. (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr. Rev. 17, 481-517 (Pubitemid 26346639)
29. Wilson, E. M., Tureckova, J., and Rotwein, P. (2004) Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol. Biol. Cell 15, 497-505 (Pubitemid 38146468)
30. Wu, Z., Woodring, P. J., Bhakta, K. S., Tamura, K., Wen, F., Feramisco, J. R., Karin, M., Wang, J. Y., and Puri, P. L. (2000) p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol. Cell. Biol. 20, 3951-3964 (Pubitemid 30314494)
31. Le Roith, D., Bondy, C., Yakar, S., Liu, J. L., and Butler, A. (2001) The somatomedin hypothesis: 2001. Endocr. Rev. 22, 53-74
32. Marshman, E., Green, K. A., Flint, D. J., White, A., Streuli, C. H., and Westwood, M. (2003) Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J. Cell Sci. 116, 675-682 (Pubitemid 36231306)
33. Shand, J. H., Beattie, J., Song, H., Phillips, K., Kelly, S. M., Flint, D. J., and Allan, G. J. (2003) Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I. J. Biol. Chem. 278, 17859-17866 (Pubitemid 36799391)
34. Ning, Y., Hoang, B., Schuller, A. G., Cominski, T. P., Hsu, M. S., Wood, T. L., and Pintar, J. E. (2007) Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene. Endocrinology 148, 2138-2147 (Pubitemid 46997078)
35. Yakar, S., Liu, J. L., Stannard, B., Butler, A., Accili, D., Sauer, B., and LeRoith, D. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. U. S. A. 96, 7324-7329 (Pubitemid 29299660)
36. Perks, C. M., McCaig, C., and Holly, J. M. (2000) Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J. Cell. Biochem. 80, 248-258 (Pubitemid 32011960)
37. Kuemmerle, J. F., and Zhou, H. (2002) Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. J. Biol. Chem. 277, 20563-20571
38. Fernandez, A. M., Dupont, J., Farrar, R. P., Lee, S., Stannard, B., and Le Roith, D. (2002) Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. J. Clin. Invest. 109, 347-355 (Pubitemid 34141808)
39. Butt, A. J., Dickson, K. A., McDougall, F., and Baxter, R. C. (2003) Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J. Biol. Chem. 278, 29676-29685 (Pubitemid 36962353)
40. Yin, P., Xu, Q., and Duan, C. (2004) Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J. Biol. Chem. 279, 32660-32666 (Pubitemid 39014724)
41. Schedlich, L. J., Muthukaruppan, A., O'Han, M. K., and Baxter, R. C. (2007) Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol. Endocrinol. 21, 2378-2390 (Pubitemid 47529352)
42. Modric, T., Silha, J. V., Shi, Z., Gui, Y., Suwanichkul, A., Durham, S. K., Powell, D. R., and Murphy, L. J. (2001) Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142, 1958-1967 (Pubitemid 32405953)
43. Silha, J. V., Gui, Y., Mishra, S., Leckstrom, A., Cohen, P., and Murphy, L. J. (2005) Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice. Endocrinology 146, 1523-1531
44. Silha, J. V., Sheppard, P. C., Mishra, S., Gui, Y., Schwartz, J., Dodd, J. G., and Murphy, L. J. (2006) Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology 147, 2112-2121
45. Leu, J. I., Crissey, M. A., Craig, L. E., and Taub, R. (2003) Impaired hepatocyte DNA synthetic response posthepatectomy in insulin-like growth factor binding protein 1-deficient mice with defects in C/EBP beta and mitogen-activated protein kinase/extracellular signal-regulated kinase regulation. Mol. Cell. Biol. 23, 1251-1259
46. Tonner, E., Barber, M. C., Allan, G. J., Beattie, J., Webster, J., Whitelaw, C. B., and Flint, D. J. (2002) Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129, 4547-4557 (Pubitemid 35203736)
47. Parker, A., Clarke, J. B., Busby, W. H., Jr., and Clemmons, D. R. (1996) Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J. Biol. Chem. 271, 13523-13529 (Pubitemid 26185396)
48. Sorrell, A. M., Shand, J. H., Tonner, E., Gamberoni, M., Accorsi, P. A., Beattie, J., Allan, G. J., and Flint, D. J. (2006) Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin. J. Biol. Chem. 281, 10883-10889 (Pubitemid 43855511)
49. Ning, Y., Schuller, A. G., Bradshaw, S., Rotwein, P., Ludwig, T., Frystyk, J., and Pintar, J. E. (2006) Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol. Endocrinol. 20, 2173-2186 (Pubitemid 44286712)
50. Chan, J. M., Stampfer, M. J., Ma, J., Gann, P., Gaziano, J. M., Pollak, M., and Giovannucci, E. (2002) Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer J. Natl. Cancer Inst. 94, 1099-1106 (Pubitemid 34830730)